Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280228
Status:
COMPLETED
Last Update Posted:
2011-05-26
First Post:
2006-01-18
Brief Title:
Home Based Treatment for Drug Use in Early Adolescents
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Home-based Behavioral Therapy HBT Psychosocial Intervention Project for Early Adolescents With Pre- or Early Substance Use Disorder Phase II
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare two programs to see if they are helpful in preventing the use of substances in adolescents with attention deficit-hyperactivity disorder ADHD oppositional defiant disorder ODD or conduct disorder CD One of the programs involves working with adolescents and their parents in their home The other program involves working with adolescents and their parents in an office setting
Detailed Description:
In this study phase 36 patients with a disruptive behavior disorder DBD - ie attention deficit-hyperactivity disorder oppositional defiant disorder conduct disorder and use or abuse of one or more substances will be randomly assigned to treatment using either a standard treatment for DBDs in this age group or the newly developed HBT treatment Treatment outcomes for the 24 patients assigned to receive HBT will then be compared to outcomes for the 12 patients assigned to receive standard DBD treatment
Specific aims of Phase II include
1 finalizing the HBT treatment manual and measures of treatment fidelity therapist competence and treatment satisfaction
2 generating estimates of treatment effect sizes for substance use disruptive behavior and functional status outcomes as pilot data for a larger efficacy study and
3 comparing treatment satisfaction for the two treatment groups
We hypothesize that HBT will lead to significantly lower rates of disruptive behaviors substance use and SUDs than with standard treatment as well as greater concomitant improvements in impairment
Specific aims of Phase II include
1 finalizing the HBT treatment manual and measures of treatment fidelity therapist competence and treatment satisfaction
2 generating estimates of treatment effect sizes for substance use disruptive behavior and functional status outcomes as pilot data for a larger efficacy study and
3 comparing treatment satisfaction for the two treatment groups
We hypothesize that HBT will lead to significantly lower rates of disruptive behaviors substance use and SUDs than with standard treatment as well as greater concomitant improvements in impairment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5R21DA016631 | NIH | None | httpsreporternihgovquickSearch5R21DA016631 |